Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Alessandro Vanasia"'
Publikováno v:
Advances in Therapy. 22:32-43
The aim of this prospective, randomized, open-label, blinded endpoint (PROBE) study was to compare the antihypertensive efficacy of 2 angiotensin II (AII) receptor antagonists with different pharmacologic profiles, valsartan and olmesartan, in patien
Autor:
Paola Preti, Elena Fogari, Amedeo Mugellini, Andrea Rinaldi, Roberto Fogari, Alessandro Vanasia, Annalisa Zoppi, Giuseppe Derosa
Publikováno v:
Current Therapeutic Research. 63:1-14
Background: The angiotensin II (AII) receptor antagonists are effective agents for the treatment of mild to moderate hypertension. Agents within this drug class differ with respect to their pharmacologic and pharmacokinetic properties, which may tran
Autor:
Annalisa Zoppi, Gianluigi Marasi, Roberto Fogari, Alessandro Vanasia, Alberto Zanchetti, Luca Corradi
Publikováno v:
Journal of Hypertension. 19:1021-1027
Studies on the effects of chronic exposure to industrial noise on clinic blood pressure (BP) at rest have yielded inconsistent results. The aim of this study was to evaluate the effect of occupational noise exposure on ambulatory blood pressure (ABP)
Autor:
Roberto Fogari, Amedeo Mugellini, Elena Fogari, Annalisa Zoppi, Paola Preti, Alessandro Vanasia, Gian Domenico Malamani
Publikováno v:
Current Therapeutic Research. 61:850-862
Background: Ankle edema is one of the most common side effects of antihypertensive treatment with calcium channel blockers (CCBs). The incidence of edema is higher with dihydropyridines than with verapamil or diltiazem. Objective: The aim of this stu
Autor:
Giuseppe Mancia, Lorena Sampieri, Alessandra Villani, Alessandro Vanasia, Paolo Palatini, Gianfranco Parati, Luisa Ulian
Publikováno v:
Scopus-Elsevier
Abstract —This study assessed whether 2 common surrogate measures of the “white-coat effect,” namely the clinic-daytime and the clinic-home differences in blood pressure (BP), were attenuated by long-term antihypertensive treatment and whether
Autor:
R.M. Pesce, Paola Preti, Roberto Fogari, Alessandro Vanasia, Amedeo Mugellini, Annalisa Zoppi, Alessandra Banderali
Publikováno v:
Current Therapeutic Research. 60:195-206
The aim of this prospective, randomized, open-label, masked, endpoint, crossover study was to compare the antihypertensive efficacy of valsartan with that of losartan—angiotensin II (Ang II) receptor antagonists with different pharmacologic profile
Autor:
Roberto Fogari, Annalisa Zoppi, Alessandro Vanasia, Gianluigi Marasi, Paola Preti, Paola Lusardi, Amedeo Mugellini
Publikováno v:
Journal of Cardiovascular Risk. 4:209-213
AIM: To evaluate heart rate and its relationship with some established cardiovascular risk factors in normotensive and hypertensive individuals. METHODS: We studied 881 1 men, 696 with essential hypertension and 8115 with normal blood pressure, strat
Autor:
Roberto Fogari, Gianluigi Marasi, Gianmarco Villa, Annalisa Zoppi, Gian Domenico Malamani, Alessandro Vanasia
Publikováno v:
European Journal of Epidemiology. 11:591-595
In order to set up a program of community control of hypertension at the work site, 8811 employees belonging to 12 factories of the same company (Agusta SpA, Italy) were screened. Seven hundred and seventy-two subjects (8%) were found to be hypertens
Autor:
G.D. Malamani, Annalisa Zoppi, Roberto Fogari, Gianluigi Marasi, Gianmarco Villa, Alessandro Vanasia
Publikováno v:
British Journal of Clinical Pharmacology. 39:471-476
1. In order to evaluate whether treatment with different antihypertensive drugs would affect plasma fibrinogen levels, 118 mild to moderate essential hypertensive subjects, all males, aged 18 to 65 years, were randomly treated with amlodipine 10 mg,
Publikováno v:
Journal of Cardiovascular Risk. 1:341-345
Background Fibrinogen levels are reported to be elevated in hypertensive patients and tend to cluster with nearly all other established cardiovascular risk factors. The aim of this study was to evaluate the relationship between plasma fibrinogen and